Stage IV Adenoid Cystic Carcinoma of the Oral Cavity
Also known as: Adenoid cystic carcinoma of the oral cavity stage IV / Stage 4 Adenoid Cystic Carcinoma of the Oral Cavity / Lip and/or oral cavity cancer stage IV
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01933 | 7-Hydroxystaurosporine | 1 | Completed | 1 |
DB12442 | Alvespimycin | 1 | Completed | 1 |
DB00112 | Bevacizumab | 1 | Completed | 1 |
DB00958 | Carboplatin | 1 | Completed | 1 |
DB00002 | Cetuximab | 1 | Completed | 2 |
DB15631 | Edodekin alfa | 1 | Completed | 1 |
DB00530 | Erlotinib | 1 | Completed | 2 |
DB01590 | Everolimus | 1 | Completed | 1 |
DB00099 | Filgrastim | 1 | Completed | 1 |
DB00544 | Fluorouracil | 1 | Completed | 1 |
DB01005 | Hydroxyurea | 1 | Completed | 1 |
DB00762 | Irinotecan | 1 | Completed | 1 |
DB15721 | Natural Killer Cell | 1 | Completed | 1 |
DB01229 | Paclitaxel | 1 | Completed | 1 |
DB00072 | Trastuzumab | 1 | Completed | 1 |
DB00112 | Bevacizumab | 1 / 2 | Completed | 1 |
DB00002 | Cetuximab | 1 / 2 | Completed | 1 |
DB00530 | Erlotinib | 1 / 2 | Completed | 1 |
DB00112 | Bevacizumab | 2 | Completed | 1 |
DB00188 | Bortezomib | 2 | Completed | 1 |
DB16741 | Bortezomib D-mannitol | 2 | Completed | 1 |
DB00997 | Doxorubicin | 2 | Completed | 1 |